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Vision
To provide a national focus for all knowledge 
related efforts that inform Irish policy in relation to
drug misuse.
Mission 
The NACD has undertaken to:
• Support the Government in significantly reducing
the health, social and economic consequences of
drug misuse through the provision of timely data
and analysis of research;
• Review its knowledge base, identifying gaps
which can be addressed through research;
• Ensure that evidence from scientific research
forms the basis for policy formulation,
development of services and continuous
improvement in all its approaches to tackling drug
misuse in Ireland; 
• Work closely with the Alcohol and Drug  Research
Unit of the Health Research Board, providing
advice, coordinating research efforts and
maximising the use of resources; 
• Support the establishment of a National
Documentation Centre; 
• Liaise with the relevant agencies nationally in
order to co-ordinate research and resources; 
• Ensure participation nationally of a broad range 
of parties in fulfilling its research needs and
dissemination of findings; 
• Serve all drug misuse reduction activities in
providing for an effective dissemination of
research findings, information and other data thus
linking research to practice. 
Values
The NACD agreed that the following values
would guide the implementation of its work
programme. The NACD will:
• Manage the diversity of its membership 
and commit to a consensus approach in 
decision-making;
• Foster a culture of respect, dignity, transparency
and fairness in all its operations; 
• Advocate dialogue as a means of balancing the
diverse views on and experiences of drug misuse
in Ireland;
• Be objective in the collection and dissemination 
of information in line with its commitment to 
the National Drugs Strategy 2001-2008;
• Commit to the highest possible standards of
excellence and ethical conduct; 
• Seek out collaborations and partnerships where
there is greater benefit to achieving its goal and
co-operate with everyone who can benefit from
its knowledge base.
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It gives me great pleasure to welcome 
the third Annual Report of the National
Advisory Committee on Drugs (NACD). 
The NACD fulfils a very important role 
in providing research-based advice to
Government in relation to drug use 
across the island of Ireland. 
Notable achievements in 2008 include 
the publication of the results of the
2006/2007 Drug Prevalence Survey, and
the publication of further findings from 
the Research Outcome Study in Ireland
(ROSIE) which focuses on the outcomes 
of opiate treatment. 
I want to congratulate Dr. Des Corrigan 
for his commitment to the work of the
NACD and for his very effective chairing 
of the Committee. I also want to thank 
the members of the Committee for their
wholehearted input to the work of the
NACD.  As well as this, the work of the
NACD is greatly enhanced through the
engagement of a significant number of
people on its sub-committees. I also 
thank them and the research and
administration staff of the NACD.
Finally, I would like to acknowledge the
commitment and hard work of the
Director, Mairéad Lyons, who is moving 
on to pursue new challenges after seven
years with the NACD. I wish her well in 
the future.
John Curran T.D.
Minister of State 
with responsibility for the National 
Drugs Strategy
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Foreword
The work of the NACD during 2008 was a
mix of both commissioned and in-house
research as well as the publication of
numerous important reports. Among the
publications were four Bulletins on the
results of the 2006/7 Population Survey on
drug use in Ireland and Northern Ireland
which have dealt with the overall pattern of
drug use on the island as well as the regional
data presented on a Regional Drugs Task
Force basis. Subsequently, detailed
prevalence, demographic and attitudinal
data on Cocaine and Cannabis have been
published. It is our hope that the wealth of
detail in these reports and the changes since
the 2002/3 Survey will provide service
providers and policy makers at local and
national levels with food for thought as
strategies develop over the next few years.
On a technical level it is not yet possible to
look at trends in these surveys as another
survey covering 2010/11 will be needed to
allow for meaningful trend data to emerge.
The three Bulletins from the ROSIE study
highlight not only what can be achieved
through treatment of those dependent on
opiates, but also the challenges  facing
services in progressing people through the
treatment journey to full recovery and
improvements in their physical and mental
health. The NACD is particularly grateful to
all those who shared a painful part of their
lives with the researchers from NUI
Maynooth so that others might benefit in
the future.
In the 2007 Annual Report, reference was
made to the collaboration between the
NACD and the National Drugs Strategy 
Team (NDST) which resulted in a joint 
report to Government on Cocaine. This 
year has seen another such fruitful
collaboration on a report on the provision 
of Needle Exchange. A number of initiatives
are underway arising from the consideration
of the report at the Inter-Departmental
Drugs Group (IDG). This is important
because implementation of NACD
recommendations is a key performance
indicator for us as the research and advisory
arm of the National Drugs Strategy.
The varied and extensive work of the
Committee would not be possible without
the expertise and commitment of those who
serve on the NACD, its Sub-committees and
Research Advisory Groups. Members give
unselfishly of their time and knowledge and
they are deserving of our gratitude for what
they continue to contribute.
The staff of the NACD are small in number
but are a dedicated hardworking group
without whom the Committee could not
have achieved what it has since its
establishment in 2000. They consistently
produce work of the highest quality   often
under constraints of time pressure. My
colleagues and I are deeply indebted to 
them for their hard work.
In particular the former Director of the
NACD, Ms Mairéad Lyons played a central
role in ensuring that our outputs were
published on time and that the highest of
standards were maintained. Her decision to
leave the Committee after seven years was
greeted with dismay not just within the
NACD but also among all who knew of her
talent and her commitment to work of the
highest quality. We all owe her a huge debt
of gratitude for the hard work and
dedication which has been so vital in
bringing the NACD to such a high level of
productivity and recognition. We will miss
her influence, energy, enthusiasm and
commitment especially her ability to prioritise
the needs of stake-holders. It is notable that
Mairéad never lost sight of the fact that all
our work, all our research, all our reports
actually dealt with real people with huge
problems. My colleagues and I wish her 
well in her new post. We know that she 
will bring her inimitable style to bear on 
the Irish Cancer Society to their benefit and
that their gain is our loss.
The continued support of the Minister of
State and his officials in the Drugs Strategy
Unit at Community, Rural and Gaeltacht
Affairs for the work of the NACD is not only
welcome but has also been an essential
element in helping us achieve so much.
Dr Des Corrigan FPSI
Chairperson
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Chairperson’s Report
Once again 2008 has been an
extraordinary year for the NACD; seven 
full Committee meetings; 22 sub-
committee meetings and 15 Research
Advisory Group meetings culminating in
the production of 15 publications, six of
which were web-only publications. The
collective wisdom and expertise of the
NACD continues to create a unique synergy
that drives its achievements. It is a
committee whose collaborative endeavours
are focused on achieving better services
and outcomes for those affected by
problem drug use and addiction.
Perhaps the highlight for 2008 has been
the production of the ROSIE 3-year
Outcomes in our ROSIE Findings series.
These findings reflect excellent
achievements for those drug users who
participated in the study and for those
service providers who have not given up on
helping people to change their lives no
matter how chaotic that life may be.  The
greatest lesson from the ROSIE Study was
that when people drop out of treatment
and return to try again, all those early 
gains are not lost but act as a foundation
from whence the drug user can move
closer to their goal.   
The NACD is staffed by a small team of
very hard-working and enthusiastic people
who never quibble when the going gets
tough and deadlines add pressure to the
working day.  I am deeply indebted to Alan
Gaffney the NACD Office Manager; to Dr
Gemma Cox the NACD Research Officer; 
to Ms Mary Jane Trimble who provides
reception and secretariat support to 
the NACD; to Dr Teresa Whitaker,
Researcher; to Ms Sheena Duffy providing
part-time administrative support and 
for a brief period in 2008 Dr Justine
Horgan, Researcher.
This is my last report for the NACD and
therefore my last opportunity to express my
deepest appreciation for the wonderful
support given to me by the NACD and in
particular its Chairman, Dr Des Corrigan.
He has provided excellent leadership and
great support, always keeping us focused
and ensuring we never lost sight of our
primary role: to provide advice to
Government on the impact drugs have 
had or are having on individuals, families
and communities. I wish to acknowledge
the four Ministers with whom I have
worked during my term with the NACD,
(Eoin Ryan TD MEP; Noel Ahern TD; Pat
Carey TD and John Curran TD). 
Finally, thank you to all those with whom 
I have worked over the last seven years
across Government (Department of
Community, Rural & Gaeltacht Affairs,
NDST, IDG, RDTFs, LDTFs), PHIRB, HSE,
members of the various NACD Research
Advisory Groups and other agencies 
such as the Family Support Network.
Mairéad Lyons
Director 
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Executive Summary 
ADRU Alcohol and Drug Research Unit of the
Health Research Board (formerly known as
the DMRD)
C&AG Comptroller and Auditor General
DSU Drugs Strategy Unit
DTMS Drug Trend Monitoring System
ED Electoral Division
FOI Freedom of Information
HIV Human Immunodeficiency Virus
HSE Health Service Executive
HRB Health Research Board
IAAAC Irish Association of Alcohol and Addiction
Counsellors
IDG Inter Departmental Group on Drugs
LDTF Local Drugs Task Force
MQI Merchants Quay Ireland
NACD National Advisory Committee on Drugs
NDST National Drugs Strategy Team 
NUI National University of Ireland
OJEU Official Journal of the European Union 
PHIRB Public Health Information and Research
Branch
PQ Parliamentary Question
RAG Research Advisory Group
RDTF Regional Drugs Task Force
RIWG Research and Information Working Group
ROSIE Research Outcome Study in Ireland
evaluating drug treatment effectiveness
UCD University College Dublin
VDTN Voluntary Drug Treatment Network
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Glossary of Terms
1.1 Origins
The NACD was established in July 2000 to advise the
Government on problem drug use in Ireland in
relation to consequences, prevalence, prevention,
and treatment including rehabilitation, based on its
analysis and interpretation of research findings and
information available to it. It also provides ‘early
warning’ advice to Government. The Committee
comprises representation from Government
Departments, Academia, Community, Voluntary and
Statutory sectors and reports to the Minister of State
with responsibility for the National Drugs Strategy.
Further information can be obtained from the
website www.nacd.ie.
Arising from a Government decision to renew the
NACD mandate in 2004, a further work programme
was developed. A consultation process was
undertaken with key interest groups and
stakeholders to explore further research and
information opportunities. The business plan
developed incorporates the continuation of the
current programme and identifies ongoing gaps in
knowledge.  The business plan was approved by 
the Cabinet Committee on Social Inclusion and is
published on the NACD website (“Business Plan
2005-2008”).
Over the years the NACD has worked closely with
other agencies and organisations to optimise skills
and resources in gathering information and filling
gaps in knowledge. In particular, the NACD works
closely with the Health Research Board’s Alcohol and
Drugs Research Unit on meeting the information
needs of the EU Five Key Indicators of Drug Use. The
NACD is engaged in ongoing collaborative work
with colleagues in the Public Health Information and
Research Branch of the Department of Health, Social
Services and Public Safety in Northern Ireland,
gathering information on drug prevalence amongst
the general population on the whole island.
The work programme and modus operandi of the
NACD is an evolving process and further information
can be obtained on the NACD website. However, its
core functions were set down by Government in
2000 and these have not altered - see over.
1.2 Functions
On its establishment in 2000, the functions of the
NACD (the Committee)  were set out as follows:
• Based on the Committee’s analysis and
interpretation of research findings and
information available to it, to advise the Cabinet
Committee on Social Inclusion and, through it, 
the Government, in relation to the prevalence,
prevention, treatment and consequences of
problem drug use in Ireland;
• To review current information sets and research
capacity in relation to the prevalence, prevention,
treatment and consequences of problem drug use
in Ireland and to make recommendations, as
appropriate, on how deficits should be addressed
including how to maximise the use of information
available from the community and voluntary
sector;
• To oversee the delivery of a three-year prioritised
programme of research and evaluation as
recommended by the Interim Advisory Committee
to meet the gaps and priority needs identified, by:
a) using the capacity of relevant agencies engaged
in information gathering and research, both
statutory and non-statutory, to deliver on
elements of the programme;
b) liaising with these agencies with a view to
maximising the resources allocated to delivering
the programme and avoiding duplication;
c) co-ordinating and advising on research projects
in the light of the prioritised programme;
d) commissioning research projects which cannot
be met through existing capacity;
e) commissioning additional research at the
request of the Government into drug issues of
relevance to policy;
• to work closely with the Health Research Board
(HRB) on the establishment of a national
information/ research database (in relation to 
the prevalence, prevention, treatment and
consequences of problem drug use) which is 
easily accessible; and
• to advise relevant Agencies with a remit to
promote greater public awareness of the issues
arising in relation to problem drug use and to
promote and encourage debate through the
dissemination of its research findings.
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Chapter One
Background and Functions of the NACD
2.1 Structures 
2.1.1 The NACD
The NACD comprises 19 members who, with the
exception of the Chairperson, participate on a
voluntary basis. Since 2005, the Chairperson receives
a small honorarium. Members serve at the invitation
of the Minister of State and their participation
requires them to sit on the NACD main committee
and at least one sub-committee. NACD meetings are
generally scheduled to take place every six weeks
excluding July and August. In 2008, seven standard
meetings, one reflection meeting and one meeting
to consider the NACD’s submission to the National
Drugs Strategy (NDS) Review were held. Full
membership is detailed in Appendix 1.
2.1.2 Sub-Committees
Due to the complexity of the drugs issue the NACD
manages its work programme through sub-
committee structures including research advisory
groups (RAGs).  There are five sub-committees in
operation: Consequences; Early Warning Emerging
Trends; Prevalence; Prevention; and
Treatment/Rehabilitation.  Each committee meets as
required and according to the needs of the NACD
work programme. In 2008, a total of 22 sub-
committee meetings were held as follows:
Consequences (3); Early Warning Emerging Trends
(5); Prevalence (6); Prevention (4); and Treatment/
Rehabilitation (4). There were a total of 15 RAG
meetings in 2008. Full sub-committee membership 
is detailed in Appendix 2.
2.1.3 Terms of Reference
Terms of Reference for sub-committees and research
advisory groups are available on the NACD website.
2.2 Work Programme of NACD
In 2001, the NACD published its first work
programme and a business plan was published in
2002. The NACD was externally reviewed by Talbot
Associates in 2004 and this led to Government
approving a renewed mandate to the end of 2008. 
A three-year business plan was published in 2005.
This set out a new work programme incorporating
projects from earlier work programmes that had still
to be completed and research that needed to be
repeated. At the beginning of each year the NACD
agrees actions for the year towards achieving its
work programme goals. 
In 2008, one new research project was
commissioned and there were eight ongoing
research projects. A total of 15 publications was
achieved; six of which were web-only publications
with the remainder printed and distributed.  
2.2.1 Summary of 2008
The ongoing work programme in 2008 comprised
the following:
• Analysis of data from the 2006/2007 Drug
Prevalence Survey; 
• Further analysis and publication of the ROSIE
study 1-year and 3-year data; 
• Completion of the evaluation of the National 
Drug Awareness Campaign;
• Ongoing fieldwork and data analysis on drug 
use and prostitution research;
• Ongoing fieldwork and literature review on a
comparative study of drug use amongst early
school leavers and attendees research; 
• Report on Needle Exchange provision in Ireland,
which was a joint project with the NDST;
• Repeat Capture Recapture Study;
• Interagency Working Briefing Paper.
Newly commissioned research was as follows:
• Research into drug markets in Ireland.
Internal work - summary of activities:
• Early School Leaving study - ongoing contact with
study centres, Ipsos MORI and the RAG - all
managed internally;
• Drug Markets Study -  monitoring and support;
N
A
C
D
 A
n
n
u
al R
ep
o
rt 2008
9
Chapter Two
Structures and Work Programme
• Drug Users, Prostitution and the Risk Environment
- completion of fieldwork, preparation of 
analysis and writing of report to NACD - all
managed internally;
• Drug Prevalence surveys - prepared and published
four bulletins, prepared confidence intervals (CIs)
for bulletins 1 and 2 (06/07 survey) and updated
2002/3 CIs;
• Review of and liaison with C&AG re Drug
Treatment Effectiveness;
• Review and guidance to research team on ROSIE
Findings 5, 6 and 7 and publications managed;
• Preparation of a DVD on the ROSIE 3-Year
outcomes;
• NDS Review - submission prepared, meetings and
consultations attended, ongoing review and
feedback of report chapter drafts;
• National Drug Awareness Campaign -
participation in meetings and launch of 
campaign event;
• Compilation and editing of Needle Exchange
Report by NACD research officer which was a joint
project with the NDST.  Report published;
• Monitoring and support to the research team on
the repeat Capture Recapture study;
• Feedback to IDG on Drug Related Deaths report
and  letter sent  to the Minister; 
• Public health notice to A&Es arising from NACD
action in relation to Cocaine adulterants 
especially lignocaine;
• Prepared the 2007 Annual Report and published 
it on the web;
• The Director represented the NACD on the
National Drugs Strategy Review Group during the
public consultation and in the preparation of the
new drugs strategy;
• The Director participated on the Traveller
Implementation Group;
• Maintenance of the website and ongoing Irish
translation of relevant uploads to website.
2.2.2 The Research Process
All research has the support of a Research Advisory
Group (RAG). The Terms of Reference for these RAGs
have been noted in previous reports and are now
available on the website. The RAG comes together
once the research question has been decided and a
commissioning process must be embarked upon.
Research is externally contracted via requests for
tenders, direct engagement or internal action. The
RAG, which generally comprises relevant
stakeholders or experts, oversees the research
process, coaching and mentoring the researchers,
advising and guiding when appropriate and
reviewing written output before finally signing off 
on a report for consideration by the NACD.
2.2.3 Commissioned Research
One research project was commissioned in 2008 as
outlined below; 
Drug Markets Study
The NACD, the Health Research Board and the
Department of Justice, Equality and Law Reform
agreed jointly to research ‘Drugs Markets’ in a
number of locations in Ireland. The shared funding
and contract arrangements were finalised and the
project commenced in 2008. A street survey was
completed in September/October and data collection
among key agencies started in November. The
Forensic Science Laboratory (FSL) will carry out a
study in support of the research, analysing drugs
samples seized for purity and potency. The NACD
and Department of Justice, Equality and Law Reform
have agreed to provide the FSL with the additional
resources required for this special initiative. The final
report is expected in December 2009.
2.2.4 Ongoing Research   
(i) Drug Use in Ireland and Northern Ireland
2006/2007 Drug Prevalence Survey 
This series of Bulletins present the key findings from
the second drug prevalence survey of households in
both Ireland and Northern Ireland. A representative
sample of people aged between 15 and 64 years
was surveyed during late 2006/early 2007, according
to the standards set by the European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA).
The data in these bulletins relate to drug prevalence
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rates on a lifetime, last year (recent) and last month
(current) basis for illegal and other drugs including
alcohol and tobacco. Statistically significant
differences in prevalence rates between 2002/3 and
2006/7 are also presented. Close collaboration with
colleagues in Northern Ireland took place to ensure
matching standards and to develop joint publications
of the data for both jurisdictions.  There were six
publications in 2008:
Drug Use in Ireland and Northern Ireland: First
Results from the 2006/2007 Drug Prevalence Survey
Bulletin 1.  Published in January 2008.
Drug Use in Ireland and Northern Ireland: First
Results from the 2006/2007 Drug Prevalence Survey.
Bulletin 1. CONFIDENCE INTERVALS. Published in
May 2008 and made available on the web only.
Drug Prevalence Survey 2006/2007. Technical
Report.  Published in May 2008 and made available
on the web only.  
Drug Use in Ireland and Northern Ireland 2006/2007
Drug Prevalence Survey: Regional Drugs Task Force
(Ireland) & Health and Social Service Board (Northern
Ireland) Results Bulletin 2. Published in June 2008. 
Drug Use in Ireland and Northern Ireland 2006/2007
Drug Prevalence Survey: Cocaine Results Bulletin 4.
Published in October 2008. 
Drug Use in Ireland and Northern Ireland 2006/2007
Drug Prevalence Survey: Cannabis Results Bulletin 3.
Published in December 2008.
Further publications on Polydrug use and Sedatives
or Tranquillisers, and Anti-depressants will issue in
2009. In addition, the NACD will analyse the data on
alcohol use across both surveys with a view to
publishing an Alcohol bulletin by summer 2009.
(ii) The Research Outcome Study in Ireland
Evaluating Drug Treatment Effectiveness 
(ROSIE Study) 
In 2002 the NACD commissioned the ROSIE Study
under Action 99 of the National Drugs Strategy.  It is
the first national, prospective longitudinal multi-site
drug treatment outcome study in the country. The
Study recruited and followed up on 404 opiate users,
from the commencement of a new treatment
episode (treatment intake) and monitored progress
at time-anchored points: 6 months; 1-year; and 3
years after treatment intake. The participants were
recruited on entry into three different types of
treatment: methadone maintenance (53.2%);
structured detoxification (20%); and abstinence-
based treatment (20.3%); and a sub-sample of
opiate users were recruited from needle-exchange
facilities (6.4%).
Four ROSIE Findings bulletins were published in
2007, the first (ROSIE Findings 1) reported on the
outcomes at 1-year for drug-use, involvement in
crime, injecting-related risk behaviour, and physical
and mental health outcomes. The subsequent three
bulletins (ROSIE Findings 2, 3 and 4) reported on 
the 1-year outcomes for each method of treatment
(detoxification, abstinence, and methadone). 
These publications are available on the NACD
website www.nacd.ie
Analysis and Publication of 1-year and 3-year data.
Further analysis of the ROSIE data for 1-year and 3-
year outcomes was ongoing at the end of 2007 and
a further three ‘ROSIE Findings’ bulletins were
published in 2008.
ROSIE Findings 5, provided analysis of the similarities
and differences by gender at 1-year follow-up.
Published in October 2008.
ROSIE Findings 6, presented a summary of 3-year
outcomes for the whole study population (follow-up
rate of 88%) described as those who completed
interviews at intake and 3 years. Published on the
website only in October 2008.
ROSIE Findings 7, presented findings for those who
completed all three interviews (follow-up 72%) at
intake to treatment, at 1-year follow-up and at 3-
years. These participants are referred to as the ‘Per
Protocol’ group. Published in October 2008.
Analysis of the ROSIE data for 3-year outcomes will
continue into 2009 and further ROSIE Findings
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publications will focus on crime, polydrug use and
predictors of treatment outcomes. 
The ROSIE Final Report is at the editing stage and
will be published and distributed early in 2009. This
report provides a comprehensive overview of the
study and presents treatment intake data and
outcomes at 1-year and 3 years.
In 2008, the NACD also commissioned a DVD to tell
the story of Drug Treatment Outcomes in Ireland and
this was completed in December. This will be
launched early in 2009 together with the final
report.
(iii) National Drug Awareness Campaign -
Complete Evaluation Report
The full report was published on the web in January
2008 and an Executive Summary was printed and
disseminated in February 2008.
(iv) Exploring the Risk Environment of
Problematic Drug Users who Engage in
Prostitution in Dublin
The NACD is acting as Principal Investigator in this
study. It was designed internally and received ethical
approval for its implementation from the Drug
Treatment Centre Board Research Ethics Committee.
Fieldwork was completed by NACD researchers in
mid-2008, data were analysed and interpreted and a
first draft of the report was sent to the NACD in
December 2008. The final report will be published
and disseminated in 2009.
(v) Comparative Study of Drug Use Among Early
School Leavers and School Attendees
The NACD is also acting as Principal Investigator in
this internally designed study. The NACD received
ethical approval for the study implementation from
the Drug Treatment Centre Board Research Ethics
Committee. The study is examining drug use among
early school leavers and school attendees in the
context of risk and protective factors. Following
completion of the pilot study, a tender issued for the
fieldwork element of the main study and this was
awarded to Ipsos MORI. Fieldwork was completed in
2008 and analysis of the data is under way. It is
anticipated that preliminary findings will be available
early in 2009.
(vi) Needle Exchange Provision in Ireland 
The NACD and NDST prepared a joint paper to the
IDG on needle exchange provision in Ireland and this
incorporated information on blood-borne viruses.
The paper “Blood-borne viruses and harm reduction
strategies: An assessment of needle exchange
provision in Ireland” was published on the website 
in December 2008.
(vii) Repeat Capture Recapture Study
This is a repeat of the Capture Recapture Study
which provided estimates on the prevalence of
problem opiate use in Ireland for the period 2000 
to 2001 using three data sources: the Central
Treatment List, Garda PULSE data and the HIPE
(Hospital In-Patient Enquiry) database. The aim of 
the repeat study is to provide updated estimates
based on data for the period 2006. The contractor,
Dr Alan Kelly from the Small Area Health Research
Unit (SAHRU) has received all the data from the
required datasets and final data cleaning is
underway. It is hoped to have preliminary figures
early in 2009.
(viii) Interagency Working Briefing Paper
The NACD prepared a briefing to Government on
Interagency working for drug prevention and this
was used to form the basis of a joint submission 
with the NDST to all departments regarding the
preparation of their strategy statements. The 
report supporting this submission is in the process 
of being completed and will be published on the
website in 2009.
2.2.5 Collaboration
Collaborative working is a core principle of the
NACD and every effort is made to involve
stakeholders at various levels in relevant discussions,
research projects and research activities. Over the last
year the NACD has been very active in collaborating
with colleagues in Northern Ireland on the All Ireland
Drug Prevalence Survey. This joint working
relationship has continued since 2002. In addition,
the NACD convened relevant stakeholders in the
various research advisory groups to support other
research projects. They involve officials from the
Departments of Education and Science; Justice,
Equality and Law Reform; Health and Children; The
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Health Research Board; The Drugs Strategy Unit; 
The Drug Treatment Centre Board; Trinity College;
National Addiction Centre, London; Ruhama;
Chrysalis; UISCE; Women’s Health Project; Gay 
Men’s Health Project; Dublin Aids Alliance; Gay 
HIV Strategies; An Garda Síochána; The Forensic
Science Laboratory; and The Customs Drugs Law
Enforcement Unit of The Revenue Commissioners.
2.2.6 NACD/NDST Collaboration
The NACD works closely with the  NDST in providing
technical support, advice and information on
tendering of research projects to Local and 
Regional Drugs Task Forces (L/RDTFs). L/RDTFs were
supported in considering  research needs in their
areas, commissioning and managing research
projects through telephone, email and face to face
meetings. The NACD also collaborated with the
NDST in 2008 to prepare a joint paper to the IDG 
on needle exchange, incorporating information on
blood-borne viruses.
2.3 Performance Management
2.3.1 Staff 
The NACD has four core posts supported directly
through secondment and contract by the
Department of Community, Rural & Gaeltacht
Affairs. The Director and Research Officer are
contracted to the Department and the Higher
Executive Officer (HEO) and part-time Clerical 
Officer (CO) are seconded from the Department.  
2.3.2 Balanced Scorecard
In 2008 the NACD had an efficiency rate of 85%.
This is in line with our targets for the year. There
were 30 internal meetings (seven of which were
team meetings) held to manage the flow of work
and to maintain the high levels of productivity from
such a small team. The remaining 23 meetings
related to the work of sub- committees, research
advisory groups and visitors to the NACD. 
Briefings to the Minister were provided on three
occasions and 52 external meetings were attended,
relating to the provision of support to the L/RDTFs, 
to other agencies and to the research programme of
the NACD.
In addition to commissioning and managing its
research, the NACD work programme generates a
range of other activities which adds another project
management dimension to the operations of the
NACD. Internal work includes providing secretariat
support to the various committees, organising
events, media relations and managing the
publication process (which involves proofing, 
editing, checking in great detail all drafts going 
to and coming from the design house and 
co-ordinating the printing process). Each publication
generates a series of activities related to planning
and organising the dissemination of reports, and 
in 2008 over 9,000 reports were circulated to 
key stakeholders.  
2.3.3 Freedom of Information (FOI)
The NACD makes most of its information available
on-line. Nonetheless, it receives FOI requests from
time to time. A reference book has been published
on the website in accordance with the requirements
of Sections 15 and 16 of the FOI Acts. In accordance
with Section 15 of the Act, the purpose of this
reference book is to facilitate access to official
information held by the NACD, by outlining the
structure, functions and details of the services
provided by the NACD, how they may be availed of,
information on the classes of records held, and
information on how to make a request to the NACD
under the Freedom of Information Acts, 1997 and
2003. Section 16 of the FOI Act requires the NACD
to publish a book containing the rules, procedures,
practices, guidelines and interpretations used by the
NACD. Copies of this publication are available at
www.nacd.ie and upon request from the offices of
the NACD.
The FOI Officer at the NACD is Mary Jane Trimble.
Alan Gaffney is the FOI Decision Maker and internal
appeals are dealt with by the Director. There were no
FOI requests in 2008.
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2.3.4 Drugs Strategy Unit (DSU) Support
The NACD provided information in response to
Parliamentary Questions (PQs) to the Drugs Strategy
Unit of the Department of Community, Rural &
Gaeltacht Affairs and provided other information 
in response to general queries on drug issues
throughout 2008. The DSU supported the NACD 
in the preparation and signing of contracts and in
the administration of financial resources allocated 
to NACD.  
The Director represented the NACD during the
National Drugs Strategy (NDS) Consultation Process,
attending eight of the 15 Public Consultation
meetings throughout the country. The Director was
also involved in the new National Drugs Strategy
drafting process, attending 23 review meetings in
total for 2008, ten of which occurred in the last four
months of 2008. This commitment was over 40
working days for the Director in support of the
Review and preparation of a new Drugs Strategy. 
2.3.5 Participation in Training
Ongoing professional development of staff
continued in 2008 through participation in various
seminars and conferences and through participation
on specific courses agreed through the professional
development plan.  These courses covered the 
areas of:
• Effective Business Writing;
• Time Management;
• Multi-level Analyis;
• Gaeilge;
• Addiction Studies;
• Software packages for data analysis SPSS, 
QSR NVivo.
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The core functions of the NACD require a
commitment to communications in its broadest
sense to promote and encourage debate and
discussion of drug issues internally and externally
amongst the wide range of stakeholders who
interact with it. The publication and distribution of
NACD research is a further dimension to using
communications tools in achieving goals. The
objectives of the communications strategy are:
• To provide timely advice and briefings to the
Minister on key issues and emerging trends;
• To advise service providers and practitioners 
across sectors of relevant research findings that
may inform current thinking and practice;
• To promote the research agenda amongst key
influencers in those agencies and bodies that
promote, commission, fund or undertake drug-
related research and/or have access to relevant
data in this field; 
• To represent the NACD and Ireland at
international fora.
3.1 Advice to Government
The NACD provided advice to Government on
several occasions during 2008 through its
participation on the IDG, in its briefings with the
Minister and through recommendations made based
on research or information it had considered. In
2008 this advice covered the areas of drug treatment
outcomes, drug prevalence, blood-borne viruses and
harm reduction strategies. The NACD also provides
ongoing advice and support to the Drugs Strategy
Unit in responding to parliamentary questions and
general queries.
3.2 Media Relations
In 2008 the NACD continued to generate
considerable media interest. Each of the five 
report launches were attended by a broad range 
of media representatives, with the Minister,
Chairperson, Director and other NACD members
participating in interviews on various issues arising
from the research.
NACD publications generate instant news coverage
and in 2008 the NACD was mentioned in news
bulletins on television, across 19 local radio stations
including four independent stations in Dublin, and
on RTE One, 2FM, Today FM and Newstalk Radio.
Fifty one interviews were given on national and
regional radio and television news and current 
affairs programmes including programmes on RTE
One, 2FM, BBC Northern Ireland, Newstalk Radio,
FM104, City Channel, Today FM and 18 other local
and regional channels. 
Forty articles relating to publications released by 
the NACD or research carried out by the NACD
appeared in national newspapers including: The 
Irish Times; The Examiner; Irish Independent group;
Irish Mirror; and Daily Star and 38 articles featured 
in regional newspapers. There were a further 23
articles published on 12 web based media sites. 
Throughout the year NACD is regularly contacted
when there has been a large seizure or when the
tragic consequences of drug misuse such as a 
fatality or serious harm occur. On these occasions,
the NACD provides factual responses on the drug
prevalence, treatment and prevention of drug 
misuse thus contributing to general awareness
among the population.
3.3 NACD Website
The website contains all the necessary information
about the NACD, including its vision, mission and
values, functions and membership. Information on
the sub-committee structure and the NACD’s
programme of work is also included.
The site has been restructured to make it more user-
friendly and has been updated to include the
research projects, events and seminars which took
place in 2008 and in previous years. Additional links
have been added to the website.
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Chapter Three
Communications
All NACD reports are published simultaneously on
the website and can be downloaded free of charge.
The website is in bilingual format - English and Irish -
thus Irish versions of annual reports, business plans,
press releases and research summaries dating from
2003 can be downloaded. 
3.4 Seminars/Briefings 2008
3.4.1 Seminars/Conferences attended by 
NACD staff in 2008 
February
Addicted to Treatment? Reflecting and rethinking
responses to client progression
Conference organised by Ballymun Local Drugs Task
Force.
Carlton Hotel, Dublin.
March
Prostitution, Policy New Directions
Organised by Eaves/Poppy Project for women in
Prostitution. 
South Bank University, London. 
First Biennial Conference of the Irish Youth Justice
Service- ‘Best Practice for Youth Justice, Best 
Practice for All’
Organised by the Irish Youth Justice Service.
Ballyconnell Cavan.
April
Safer Injecting Seminar: An Injection of Common
Sense 
A seminar focussing on reducing the harm
associated with injecting drug use and promoting
positive health responses.
Organised by Merchants Quay Ireland.   
Launch of the MQI: Safer Injecting Guide by Minister
of State, Pat Carey TD. 
International Society for the Study of Drug Policy
(ISSDP) Conference
Themes: Developing drug policy evaluation, defining
drug policy models, the integrated approach to licit
and illicit drugs, security and nuisance concerns.
Supported by the EMCDDA and Instituto da Droga 
e da Toxicodependencia (IDT).
Lisbon. 
SIPTU
Joint Trade Union-Community Seminar on Drugs 
and Alcohol 2008
The Dublin CityWide Drugs Crisis Campaign in
conjunction with SIPTU's Dublin Regional Executive
Committee hosted a half day seminar in order to: 
Develop awareness of the drugs and alcohol issue
among union members; Identify practical responses
that can be developed and supported by the unions;
Engage with the partners who will be involved in
these responses - such as the community sector,
employers, State agencies and Government.
Liberty Hall Theatre, Dublin.
May
Women in Prison, The Need for a Critical Review
Keynote speaker: Baroness Jean Corston.
Jesuit Centre for Faith & Justice.
The Bar Council Law Library, Dublin.
June 
Ana Liffey Project: Annual Report Launch 
Gay Health 
Organised by the Gay Men’s Health Project.
Dublin Castle.
September
First Global Conference on Methamphetamine,
Science Strategy and Response.
Methamphetamine (MA) global prevalence,
epidemiological and ethnographic perspectives,
clinical and psychological challenges and the legal
framework guiding drugs policy and strategies.
Prague.
Economic Development 50 Years On 1958-2008
Institute of Public Administration in association 
with the Department of Finance.
Dublin Castle.
October 
Family Matters: Exploring Key Concepts, Principles
and Practices In Relation to Addiction and the Family
Organised by Ballymun Local Drugs Task Force.
Carlton Airport Hotel, Santry. 
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3.4.2 Presentations given by the NACD 
during 2008
February
Launch of the National Drug Awareness Campaign
Ms. Mairéad Lyons made a presentation.
Mansion House Dublin.
March
NDS Review 
Ms Mairéad Lyons made a presentation to the 
NACD about the NDS review.
April
CityWide Drugs Crisis Campaign Conference
Dr Gemma Cox made a presentation.
July
NDS Review Group
Dr Teresa Whitaker made a presentation on the
recommendations arising from the research on Drug
Use, Sex Work and the Risk Environment in Dublin.
November
Workplace Drug Testing
Dr Teresa Whitaker made a presentation to a 
SIPTU conference.
Wexford.
3.5 Publications and Submissions
1. NACD Papers on Rehabilitation submitted to
working group in 2005 and published on the
Web only January 2008. www.nacd.ie.
2. Sixsmith, J., NicGabhainn, S. (2008) Evaluation
of the National Drug Awareness Campaign.
Full Research Report published on the Web only
January 2008. www.nacd.ie.
3. Drug Use in Ireland and Northern Ireland
First results from the 2006/2007 Drug
Prevalence Survey Bulletin 1. Published in
January 2008.
4. Sixsmith, J., NicGabhainn, S. (2008) Evaluation
of the National Drug Awareness Campaign.
Executive Summary printed for dissemination.
Published in February 2008.
5. Drug Use in Ireland and Northern Ireland. First
results from the 2006/2007 drug prevalence
survey.  Bulletin 1. CONFIDENCE INTERVALS.
Published in May 2008 and available on the 
Web only. www.nacd.ie.
6. Drug Prevalence Survey 2006/2007 Technical
Report. Published in May 2008 and available 
on the Web only. www.nacd.ie.
7. Drug Use in Ireland and Northern Ireland
2006/2007 Drug Prevalence Survey: Regional
Drugs Task Force (Ireland) & Health and
Social Service Board (Northern Ireland)
Results Bulletin 2. Published in June 2008.
8. Cox, G, Kelly P, Comiskey C (2008). ROSIE
Findings 5 Gender Similarities and
Differences in Outcomes at 1-Year. Published
by NACD in September 2008.
9. Comiskey C, Kelly P, Stapleton R (2008). ROSIE
Findings 6 A Summary of Outcomes at 3-
Years. Published by NACD in October 2008 and
available on the Web only. www.nacd.ie.
10. Comiskey C, Kelly P, Stapleton R (2008). ROSIE
Findings 7 A Summary of Outcomes for the
Per-Protocol Population. Published by NACD 
in October 2008.
11. Drug Use in Ireland and Northern Ireland
2006/2007 Drug Prevalence Survey: Cocaine
Results Bulletin 4. Published in October 2008.
12. Drug Use in Ireland and Northern Ireland
2006/2007 Drug Prevalence Survey:
Cannabis Results Bulletin 3. Published in
December 2008.
13. Needle exchange provision in Ireland. 
A Joint paper by the NDST and NACD.
Published December 2008 and available on 
the Web only. www.nacd.ie.
14. Annual Report 2007. Published on web
December 2008.
15. Research summaries published in December
2008 with Annual Report.
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4.1 Research - Funding Allocations
(for Research Projects Commissioned in 2008)
(includes VAT where applicable)
Research Advisory Groups
Drug Markets Study €189,237.95  
Alcohol and Drugs Research Unit, Health Research Board
(The NACD contributed €111,390.36 towards the total cost of the study with the 
Dept. of Justice, Equality & Law Reform providing €27,847.59. The Health Research 
Board made a contribution of €50,000)
Supporting Actions/Activities
Media Relations
Montague Communications €23,690.28
Total NACD Allocation €135,080.64
4.2 NACD Expenditure
An annual budget of approximately €1.3 million was allocated by the Department 
of Community, Rural and Gaeltacht Affairs towards the operation of the NACD. 
Seventy per cent of this budget is allocated to research funding and the remaining 
30% to general administration.
The figures presented are a description of NACD expenditure on research and general 
administration for 2008. NACD finance is integrated within the general accounts of 
the Department of Community, Rural and Gaeltacht Affairs.
NACD expenditure on new and existing research projects, including external expert 
support, for 2008 €639,896.87
NACD expenditure on general administration, including pay, media relations and 
legal services for 2008 €343,331.82
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Chapter Four
Finance
Chairperson
Dr Des Corrigan, Visiting Academic, School of
Pharmacy and Pharmaceutical Sciences, Trinity
College
Vice-Chairperson
Dr Mary Ellen McCann, Academic Appointment
Members
Prof Joe Barry, Academic Appointment
Ms Jackie Blanchfield, VDTN 
Mr Michael Conroy, Dept. of Community, 
Rural & Gaeltacht Affairs
Senator Maria Corrigan, Clinical Psychologist
Mr Joseph Doyle, HSE 
Ms Anna Quigley, Community Sector
Mr John Garry, Dept. of Justice, Equality & 
Law Reform
Ms Mairéad Kavanagh, VDTN
Dr Eamon Keenan, Consultant Psychiatrist, 
HSE South Western Area 
Dr Jean Long, ADRU, Health Research Board
Mr Eamon Corcoran, Dept. of Health and Children
Supt Barry O’Brien, Garda National Drugs Unit
Mr Liam O’Brien, Community Sector
Ms Mary O’Shea, IAAAC
Dr Máirín O’Sullivan, Dept. of Education & Science 
Ms Vivienne Fay, HSE 
Vacancy, NDST
Retired NACD Members (2008)
Ms Sunniva Finlay, Community Sector
Mr David Moloney, Dept. of Health & Children
Ms Patricia O’Connor, NDST
Members of Sub-committees
throughout 2008 (Not sitting on 
Main Committee)
Consequences
Ms Alison O’Reilly, Dept. of Justice, Equality 
& Law Reform
Dr Hugh Gallagher, HSE
Ms Margaret O’Gorman, Dept. of Justice, Equality 
& Law Reform 
Mr Gabriel Staunton, Dept. of Community, Rural 
& Gaeltacht Affairs
Early Warning/Emerging Trends
Dr Daniel O’Driscoll, Forensic Science Laboratory
Dr Bobby Smyth, HSE South Western Area
Ms Jean Burdette, Drug Treatment Centre Board
Ms Siobhan Stokes, State Laboratory / Drug
Treatment Centre Board
Dr Richie Maguire, Medical Bureau of Road Safety
Ms Noreen Quinn, Dept. of Health & Children
Ms Maria Ryan, Revenue Commissioners
Ms Breda O’Shea, Revenue Commissioners
Mr Gerry Hayes, Dept. of Justice, Equality 
& Law Reform
Det Garda Pat Davis, Garda National Drugs Unit
Ms Anya Pierce, Toxicology Department, 
Beaumont Hospital
Ms Helen Crosse, Toxicology Department, 
Beaumont Hospital
Mr Michael McDonagh, Crosscare Drug & 
Alcohol Programme
Mr Andy Osborne, Crosscare Drug & Alcohol
Programme
Ms Niamh Arthur, Irish Medicines Board
Dr James Gray, Emergency Dept. AMNCH
Mr Liam Regan, State Laboratory 
Ms Fiona Walsh, HSE Western Area
Mr Gabriel Staunton, Dept. of Community, 
Rural & Gaeltacht Affairs 
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Appendix One
Membership of NACD Committee at 
31st December 2008
Prevalence 
Mr Barry McGreal, Dept. of Justice, Equality 
& Law Reform
Mr Eddie Arthurs, Dept. of Community, Rural 
& Gaeltacht Affairs 
Prevention
Mr Robbie Breen, Dept. of Health & Children
Ms Ruby Morrow, Church of Ireland College 
of Education
Ms Mary Johnston, Walk Tall Programme 
Support Services
Mr Bill Ebbitt, HSE
Ms Marie Mc Bride, Dept. of Community, 
Rural & Gaeltacht Affairs 
Ms Linda O’Rourke, Dept. of Community, 
Rural & Gaeltacht Affairs
Treatment
Ms Anna May Harkin, Dept. of Health & Children
Mr Alan Bell, Dept. of Health & Children
Dr Íde Delargy, Irish College of General Practitioners
Ms Frances Nangle-Connor, Irish Prison Service
Mr Tony Barden, HSE South East Region  
Ms Linda O’Rourke, Dept. of Community, Rural
& Gaeltacht Affairs
Ms Marie McBride, Dept. of Community, Rural 
& Gaeltacht Affairs
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Appendix Two
Table of Sub-Committee Membership at 
31st December 2008
Consequences EWET Prevalence Prevention Treatment
Dr Des Corrigan Visiting Academic, 
School of Pharmacy 
& Pharmaceutical 
Sciences, Trinity College   
Dr Mary Academic Appointment
Ellen McCann  
Prof Joe Barry Academic Appointment  
Ms Jackie VDTN
Blanchfield  
Senator Maria  Clinical Psychologist
Corrigan  
Ms Anna Quigley Community Sector  
Ms Mairéad VDTN
Kavanagh  
Dr Eamon Keenan Consultant Psychiatrist,
HSE South Western Area  
Dr Jean Long ADRU, Health 
Research Board    
Mr Eamon Department of Health 
Corcoran and Children  
Mr Joseph Doyle HSE 
Supt Barry O'Brien Garda National 
Drugs Unit  
Mr Liam O'Brien Community Sector  
Vacancy NDST   
Ms Mary O'Shea IAAAC  
Dr Máirín Department of  
O'Sullivan Education and Science 
Mr Gabriel Department of  
Staunton Community, Rural & 
Gaeltacht Affairs  
Ms Alison Reilly Department of Justice, 
Equality and 
Law Reform 
Dr Hugh Gallagher HSE 
Dr James Gray Emergency Dept. 
AMNCH 
Mr Gerry Hayes Department of Justice,  
Equality and 
Law Reform 
Det Garda Garda National 
Pat Davis Drugs Unit 
Mr Liam Regan State Laboratory 
N
A
C
D
 A
n
n
u
al
 R
ep
o
rt
 2
00
8
22
Consequences EWET Prevalence Prevention Treatment
Dr Daniel Forensic Science 
O'Driscoll Laboratory 
Ms Noreen Quinn Department of Health 
and Children 
Ms Helen Crosse Toxicology Department 
Beaumont Hospital 
Dr Bobby Smyth HSE, South 
Western Area 
Dr Richie Maguire Medical Bureau of 
Road Safety 
Ms Maria Ryan Revenue Commissioners 
Mr Andy Osborn Crosscare Drug & 
Alcohol Programme 
Ms Niamh Arthur Irish Medicines Board 
Ms Fiona Walsh HSE Western Area 
Ms Siobhan Stokes Drug Treatment 
Centre Board 
Mr Eddie Arthurs Department of 
Community, Rural & 
Gaeltacht Affairs 
Mr Barry McGreal Department of Justice, 
Equality and 
Law Reform 
Mr Robbie Breen Department of Health 
and Children 
Ms Ruby Morrow Church of Ireland 
College of Education 
Ms Mary Johnston Walk Tall Programme 
Support services 
Mr Bill Ebbitt HSE 
Ms Marie McBride Department of 
Community, Rural & 
Gaeltacht Affairs  
Ms Anna Department of Health 
May Harkin and Children 
Mr Alan Bell Department of Health 
and Children 
Mr Tony Barden HSE South East Region 
Dr Íde Delargy Irish College of 
General Practitioners 
Ms Frances Irish Prison Service
Nangle-Connor 
In the National Drugs Strategy 2001-2008, the
NACD was requested to undertake the following
actions.
98 To carry out studies on drug misuse amongst
the at risk groups identified e.g. Travellers,
prostitutes, the homeless, early school leavers
etc. including de-segregation of data on these
groups. It is essential that the individuals and
groups most affected by drug misuse and
those involved in working to reduce, treat and
prevent drug misuse have immediate access to
relevant statistical information. 
99 To commission further outcome studies, 
within the Irish setting to establish the current
impact of methadone treatment on both
individual health and on offending behaviour.
Such studies should be an important tool in
determining the long term value of this
treatment. 
100 To conduct research into the effectiveness of
new mechanisms to minimise the sharing of
equipment e.g. non-reusable syringes, mobile
syringe exchange facilities etc. to establish the
potential application of new options within
particular cohorts of the drug using population
i.e. amongst younger drug misusers, within
prisons etc
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Appendix Three
Actions Required of the NACD under 
the National Drugs Strategy
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